Fatemeh Talebian, Ph.D.
Affiliations: | 2012 | Integrated Biomedical Science Graduate Program (IBGP) | Ohio State University, Columbus, Columbus, OH |
Area:
ImmunologyGoogle:
"Fatemeh Talebian"Mean distance: (not calculated yet)
Parents
Sign in to add mentorXue-Feng Bai | grad student | 2012 | Ohio State | |
(CD200-CD200R Interaction in Tumor Immunity.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lin CH, Talebian F, Yang L, et al. (2023) CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells. Iscience. 26: 106904 |
Shi Y, Zhu J, Liu JQ, et al. (2022) CD24 is expressed on FoxP3 regulatory T cells and regulates their function. American Journal of Translational Research. 14: 2291-2300 |
Hu A, Zhu J, Zeng C, et al. (2022) IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. Journal of Immunology (Baltimore, Md. : 1950). 208: 2239-2245 |
Liu JQ, Zhang C, Zhang X, et al. (2022) Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Talebian F, Yu J, Lynch K, et al. (2021) CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 9: 739816 |
Liu JQ, Hu A, Zhu J, et al. (2020) CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. Advances in Experimental Medicine and Biology. 1223: 155-165 |
Liu JQ, Talebian F, Wu L, et al. (2016) A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. Journal of Immunology (Baltimore, Md. : 1950) |
Wang L, Liu JQ, Talebian F, et al. (2015) IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology. 4: e1014232 |
Liu Z, Liu JQ, Talebian F, et al. (2013) IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. European Journal of Immunology. 43: 468-79 |
Talebian F, Bai XF. (2012) The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy. Oncoimmunology. 1: 971-973 |